Doug Saffran
Publications by Year
Research Areas
Wnt/β-catenin signaling in development and cancer, Cancer-related gene regulation, Lung Cancer Treatments and Mutations, Prostate Cancer Treatment and Research, Cancer-related Molecular Pathways
Most-Cited Works
- → Structure-Based Design of 2-Aminopyridine Oxazolidinones as Potent and Selective Tankyrase Inhibitors(2013)31 cited
- → Structure-Based Design of Potent and Selective CK1γ Inhibitors(2012)21 cited
- → Abstract 1795: Characterization of a novel series of potent, selective inhibitors of wild type and mutant/fusion anaplastic lymphoma kinase(2012)11 cited
- → Structure-Based Design of Potent and Selective CK1 gamma Inhibitors.(2012)1 cited
- → Abstract 1771: Targeting oncogenic transcription in prostate cancer with a novel, oral bioavailable, and ultra-selective CDK9 inhibitor(2020)